Specialty products innovation

Pioneering solutions to fight disease: Innovation at Teva Canada

Innovation is central to our culture and strategy. It underpins our goal of enabling people to have greater control over their health and live life to its fullest potential.

We work to develop branded, specialty medicines and partner to bring novel delivery systems and support services to patients and healthcare professionals.

For us, innovation means developing safe, effective, and well-tolerated products. It means promoting new approaches and pioneering solutions to fight diseases such as migraine, multiple sclerosis, Parkinson’s disease, and cancer, as well as disorders affecting the neurological, immune, and respiratory systems.

Above all, it means creating an ecosystem of care for those affected by these diseases, because we know that quality of life and health go hand-in-hand. Maintaining close relationships with healthcare professionals and patient families remains an integral part of our mission.

Working closely with our partners, we are prioritizing the development of new products and medical technologies in the therapeutic areas of central nervous system (CNS), respiratory, oncology and pain care.


Growing our pipeline in the CNS, respiratory, oncology and pain care therapeutic areas is a priority for Teva. We have an exciting pipeline of products currently in development around the world.

Learn about or global Teva pipeline

Here in Canada, our growth strategy addresses the rapid pace of change in health markets, and the increasing trend toward patient-centred care and personalized medicine.

Research & development: Medical Affairs

The Teva Canada Medical Affairs team is responsible for providing medical support to our company (both branded and generics), and for interacting with external customers through medical information and medical education.

The goal of Medical Affairs is to advance our medical knowledge in key therapeutic areas, including neurological disorders, oncology, pain management and respiratory diseases. The team supports patients and healthcare professionals by providing medical information, scientific communications and educational activities.

Our Medical Affairs team works closely with our US counterparts and in close collaboration with Teva’s Global Clinical Research Group. Teva Canada also supports Canadian Investigator Initiated Studies.

Through a range of activities, Medical Affairs ensures that Canadian healthcare professionals are well informed about the safety and efficacy profile of Teva’s products to support the proper use of our drugs.

Research partnerships

Should you or your organization be interested in partnering in a research initiative, please contact Medical Affairs to learn about the process you should follow.